drugset / Trial / NCT00720382
A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if one allergy treatment (0.15% azelastine hydrochloride) is as safe as mometasone furoate (nasonex) alone.
Timeline
- Start
- 2007-03
- Primary completion
- 2008-06
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azelastine | Small molecule | 1644 ug | Intranasal |
| Subject | Mometasone furoate | Other / unclassified | 200 ug | Intranasal |